News Focus
News Focus
icon url

TheFinalCD

11/12/13 1:34 PM

#169826 RE: DewDiligence #169785

OXGN $3.77 heading to test HOD
icon url

DewDiligence

12/02/13 4:03 PM

#170712 RE: DewDiligence #169785

Kindred Biosciences (KIN) lowers IPO target:

http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/12/kindred-biosciences-kin-pet-drugs.html

The one-year-old Burlingame company, which said Nov. 11 that it planned to raise $57.5 million, on Monday downgraded the top of its initial public offering range to $46 million. It said it would offer 5.75 million shares, probably at $6 to $8 per share.